TYRA BROWN: Open Payments
NPI 1275187874 · JEFFERSON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 31 payments from 8 companies in 2025. Trend: 2023 $631 · 2024 $614 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $368 |
| Boston Scientific Corporation | 5 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| Tonix Medicines, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| SCILEX PHARMACEUTICALS INC. | 1 | $14 |
Products named: QULIPTA, UBRELVY, Intracept, RELISTOR, General - Pain Management, TONMYA, Exparel, WaveWriter Alpha Prime 16.
Industry payments across LA — which companies pay providers there.
